BBVA USA’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$6.19M Sell
38,342
-2,474
-6% -$422K 0.36% 61
2021
Q2
$6.72M Buy
+40,816
New +$6.76M 0.37% 59

Other funds holding JNJ

BBVA USA's JNJ Position: Q3 2021 in Review

BBVA USA reduced its Johnson & Johnson (JNJ) stake by 6.1% in Q3 2021, selling an estimated $422K and leaving 38,342 shares worth $6.19M. The position accounts for 0.36% of the portfolio, ranked #61.

BBVA USA first reported a position in JNJ in Q2 2021 and has held it in 2 quarters since. The position peaked at $6.72M in Q2 2021. 3,312 funds tracked by Wall St. Rank hold JNJ as of Q3 2021.

  • BBVA USA held 38,342 shares of Johnson & Johnson worth $6.19M as of Q3 2021.
  • BBVA USA sold 2,474 Johnson & Johnson shares in Q3 2021, an estimated $422K.
  • Johnson & Johnson made up 0.36% of BBVA USA's portfolio in Q3 2021, its #61 holding.
  • BBVA USA first reported a position in Johnson & Johnson in Q2 2021 and has held it in 2 quarters since.
  • BBVA USA's Johnson & Johnson position peaked at $6.72M in Q2 2021.
  • 3,312 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.